Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 7, 2006; 12(25): 4004-4008
Published online Jul 7, 2006. doi: 10.3748/wjg.v12.i25.4004
Published online Jul 7, 2006. doi: 10.3748/wjg.v12.i25.4004
Groups | 24 h | 48 h | 72 h | 96 h |
Control | 0.48 ± 0.10 | 0.60 ± 0.10 | 0.61 ± 0.03 | 0.65 ± 0.05 |
NS-ODN (6 μmol/L) | 0.50 ± 0.07 | 0.61 ± 0.19 | 0.60 ± 0.08 | 0.66 ± 0.19 |
ANS-ODN (1 μmol/L) | 0.60 ± 0.03 | 0.48 ± 0.06 | 0.37 ± 0.03 | 0.31 ± 0.05 |
ANS-ODN (2 μmol/L) | 0.56 ± 0.02 | 0.47 ± 0.09 | 0.34 ± 0.04 | 0.29 ± 0.03 |
ANS-ODN (4 μmol/L) | 0.51 ± 0.10 | 0.39 ± 0.08 | 0.33 ± 0.04 | 0.28 ± 0.03 |
ANS-ODN (6 μmol/L) | 0.43 ± 0.10 | 0.27 ± 0.02 | 0.26 ± 0.06 | 0.19 ± 0.00 |
-
Citation: Wang YF, Guo KJ, Huang BT, Liu Y, Tang XY, Zhang JJ, Xia Q. Inhibitory effects of antisense phosphorothioate oligodeoxynucleotides on pancreatic cancer cell Bxpc-3 telomerase activity and cell growth
in vitro . World J Gastroenterol 2006; 12(25): 4004-4008 - URL: https://www.wjgnet.com/1007-9327/full/v12/i25/4004.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i25.4004